This prediction market asks which flavors JUUL Labs will relaunch by January 1, 2027. JUUL, once the dominant e-cigarette company in the United States, faced a major regulatory crackdown in 2020 when the U.S. Food and Drug Administration (FDA) ordered the removal of all flavored products except tobacco and menthol from the market. The company had been widely criticized for marketing fruit and dessert flavors like mango, mint, and creme brulee to teenagers, contributing to a surge in youth vaping rates. JUUL subsequently stopped selling those flavors in retail stores and later online, but the question now is whether the company will reintroduce them as part of a potential comeback strategy. JUUL's current situation is precarious. In June 2022, the FDA issued a marketing denial order (MDO) for all JUUL products, effectively banning them from the U.S. market. JUUL successfully appealed and received a temporary stay, but the agency later reversed its decision and accepted JUUL's applications for review. As of late 2024, JUUL products remain on sale under a temporary reprieve, but the company's long-term viability depends on FDA approval. JUUL also settled thousands of lawsuits for over $1.2 billion in 2022-2023, including a $462 million settlement with six states and Washington D.C. and a $255 million settlement with the state of California. JUUL's potential flavor relaunch is tied to its efforts to reposition itself as a harm reduction tool for adult smokers. The company has invested in new product development, including a Bluetooth-enabled device with age verification features, and has signaled interest in re-entering the flavor market if regulators approve. However, the FDA's stance on flavored e-cigarettes remains strict, and any flavor reintroduction would likely require a successful premarket tobacco product application (PMTA) showing that the flavors provide a net benefit to public health by helping adult smokers quit without appealing to youth. People are interested in this topic because it represents a potential shift in the U.S. vaping landscape. If JUUL relaunches flavors, it could signal a relaxation of FDA restrictions or a successful demonstration that flavored products can be sold with adequate youth protections. Conversely, a failure to relaunch would confirm the FDA's continued hostility toward flavored e-cigarettes. The outcome also affects investors, public health advocates, and the millions of adult vapers who prefer flavored products.

Historical Context

JUUL launched in 2015 as a sleek, pod-based vaping device that quickly became the most popular e-cigarette in the United States. By 2018, JUUL controlled over 70% of the U.S. e-cigarette market. The company initially sold flavors like mango, mint, fruit medley, and creme brulee, which were widely popular, especially among teenagers. A 2018 National Youth Tobacco Survey found that 20.8% of high school students reported using e-cigarettes, up from 11.7% in 2017, with JUUL being the most common brand. This youth vaping epidemic prompted the FDA to declare youth vaping an 'epidemic' in September 2018. In response to mounting pressure, JUUL voluntarily stopped selling its flavored pods in retail stores in November 2018, but continued sales online with age verification. The company also shut down its social media accounts and replaced its CEO. In January 2020, the FDA issued an enforcement policy that prioritized removal of unauthorized flavored pod-based e-cigarettes, effectively banning all flavors except tobacco and menthol from the market. JUUL complied by halting sales of mango, mint, creme brulee, and fruit flavors nationwide. JUUL's legal and regulatory troubles deepened in 2022. On June 23, 2022, the FDA issued a marketing denial order for all JUUL products, stating that the company's applications lacked sufficient evidence to show that the products were appropriate for the protection of public health. JUUL immediately appealed and the U.S. Court of Appeals for the D.C. Circuit granted a temporary stay, allowing products to remain on the market. In July 2022, the FDA reversed its decision and placed JUUL's applications back under review. As of late 2024, the FDA has not made a final determination, leaving JUUL in regulatory limbo. JUUL also faced thousands of lawsuits from school districts, states, and individuals alleging that the company intentionally marketed to minors. In December 2022, JUUL agreed to pay $1.2 billion to settle over 5,000 lawsuits, including a $462 million settlement with six states and Washington D.C. In April 2023, the company settled with California for $255 million. These settlements have strained JUUL's finances, leading to layoffs and cost-cutting measures.